N-linked glycosylation and homeostasis of the endoplasmic reticulum

Current Opinion in Cell Biology

Volumn 41, Issue , 2016, Pages 57-65

  Cherepanova, Natalia ^a   Shrimal, Shiteshu ^a   Gilmore, Reid ^a  

^a UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE REGULATED PROTEIN 94; GLYCAN; GLYCOPROTEIN; GUANINE NUCLEOTIDE BINDING PROTEIN; LECTIN; LIPOOLIGOSACCHARIDE; MANNOSE; MANNOSIDASE; OLIGOSACCHARIDE; OXIDOREDUCTASE; PROTEIN MAGT1; PROTEIN STT3B; PROTEIN TUSC3; UNCLASSIFIED DRUG; POLYSACCHARIDE;

BINDING SITE; CONGENITAL DISORDER OF GLYCOSYLATION; ENDOPLASMIC RETICULUM; ENDOPLASMIC RETICULUM ASSOCIATED DEGRADATION; ENDOPLASMIC RETICULUM STRESS; GENE MUTATION; HOMEOSTASIS; HUMAN; N LINKED GLYCOSYLATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN GLYCOSYLATION; PROTEIN UNFOLDING; REVIEW; UNFOLDED PROTEIN RESPONSE; ANIMAL; GLYCOSYLATION; METABOLISM;

ANIMALS; ENDOPLASMIC RETICULUM; ENDOPLASMIC RETICULUM-ASSOCIATED DEGRADATION; GLYCOPROTEINS; GLYCOSYLATION; HOMEOSTASIS; HUMANS; POLYSACCHARIDES;

EID: 84962877719     PISSN: 09550674     EISSN: 18790410     Source Type: Journal    
DOI: 10.1016/j.ceb.2016.03.021     Document Type: Review

References (66)

1. Tannous A., Pisoni G.B., Hebert D.N., Molinari M. N-linked sugar-regulated protein folding and quality control in the ER. Semin Cell Dev Biol 2015, 41:79-89.
2. Caramelo J.J., Parodi A.J. A sweet code for glycoprotein folding. FEBS Lett 2015, 589:3379-3387.
3. Benyair R., Ogen-Shtern N., Lederkremer G.Z. Glycan regulation of ER-associated degradation through compartmentalization. Semin Cell Dev Biol 2015, 41:99-109.
4. Gardner B.M., Pincus D., Gotthardt K., Gallagher C.M., Walter P. Endoplasmic reticulum stress sensing in the unfolded protein response. Cold Spring Harb Perspect Biol 2013, 5:a013169.
5. Zielinska D.F., Gnad F., Schropp K., Wisniewski J.R., Mann M. Mapping N-glycosylation sites across seven evolutionarily distant species reveals a divergent substrate proteome despite a common core machinery. Mol Cell 2012, 46:542-548.
6. Zielinska D.F., Gnad F., Wisniewski J.R., Mann M. Precision mapping of an in vivo N-glycoproteome reveals rigid topological and sequence constraints. Cell 2010, 141:897-907.
7. Kelleher D.J., Karaoglu D., Mandon E.C., Gilmore R. Oligosaccharyltransferase isoforms that contain different catalytic STT3 subunits have distinct enzymatic properties. Mol Cell 2003, 12:101-111.
8. Shibatani T., David L.L., McCormack A.L., Frueh K., Skach W.R. Proteomic analysis of mammalian oligosaccharyltransferase reveals multiple subcomplexes that contain Sec61, TRAP, and two potential new subunits. Biochemistry 2005, 44:5982-5992.
9. Roboti P., High S. The oligosaccharyltransferase subunits OST48, DAD1 and KCP2 function as ubiquitous and selective modulators of mammalian N-glycosylation. J Cell Sci 2012, 125:3474-3484.
10. Reiss G., te Heesen S., Gilmore R., Zufferey R., Aebi M. A specific screen for oligosaccharyltransferase mutations identifies the 9 kDa OST5 protein required for optimal activity in vivo and in vitro. EMBO J 1997, 16:1164-1172.
11. Blomen V.A., Majek P., Jae L.T., Bigenzahn J.W., Nieuwenhuis J., Staring J., Sacco R., van Diemen F.R., Olk N., Stukalov A., et al. Gene essentiality and synthetic lethality in haploid human cells. Science 2015, 350:1092-1096.
12. Shrimal S., Trueman S.F., Gilmore R. Extreme C-terminal sites are posttranslocationally glycosylated by the STT3B isoform of the OST. J Cell Biol 2013, 201:81-95.
13. Shrimal S., Cherepanova N.A., Gilmore R. Cotranslational and posttranslocational N-glycosylation of proteins in the endoplasmic reticulum. Semin Cell Dev Biol 2015, 41:71-78.
14. Cherepanova N.A., Shrimal S., Gilmore R. Oxidoreductase activity is necessary for N-glycosylation of cysteine-proximal acceptor sites in glycoproteins. J Cell Biol 2014, 206:525-539.
15. Hasan M., Fermaintt C.S., Gao N., Sakai T., Miyazaki T., Jiang S., Li Q.Z., Atkinson J.P., Morse H.C., Lehrman M.A., et al. Cytosolic nuclease TREX1 regulates oligosaccharyltransferase activity independent of nuclease activity to suppress immune activation. Immunity 2015.
16. Schallus T., Feher K., Sternberg U., Rybin V., Muhle-Goll C. Analysis of the specific interactions between the lectin domain of malectin and diglucosides. Glycobiology 2010, 20:1010-1020.
17. Schallus T., Jaeckh C., Feher K., Palma A.S., Liu Y., Simpson J.C., Mackeen M., Stier G., Gibson T.J., Feizi T., et al. Malectin: a novel carbohydrate-binding protein of the endoplasmic reticulum and a candidate player in the early steps of protein N-glycosylation. Mol Biol Cell 2008, 19:3404-3414.
18. Galli C., Bernasconi R., Solda T., Calanca V., Molinari M. Malectin participates in a backup glycoprotein quality control pathway in the mammalian ER. PLoS ONE 2011, 6:e16304.
19. Chen Y., Hu D., Yabe R., Tateno H., Qin S.Y., Matsumoto N., Hirabayashi J., Yamamoto K. Role of malectin in Glc(2)Man(9)GlcNAc(2)-dependent quality control of alpha1-antitrypsin. Mol Biol Cell 2011, 22:3559-3570.
20. Qin S.Y., Hu D., Matsumoto K., Takeda K., Matsumoto N., Yamaguchi Y., Yamamoto K. Malectin forms a complex with ribophorin I for enhanced association with misfolded glycoproteins. J Biol Chem 2012, 287:38080-38089.
21. Takeda K., Qin S.Y., Matsumoto N., Yamamoto K. Association of malectin with ribophorin I is crucial for attenuation of misfolded glycoprotein secretion. Biochem Biophys Res Commun 2014, 454:436-440.
22. Whitley P., Nilsson I.M., von Heijne G. A nascent secretory protein may traverse the ribosome/endoplasmic reticulum translocase complex as an extended chain. J Biol Chem 1996, 271:6241-6244.
23. Deprez P., Gautschi M., Helenius A. More than one glycan is needed for ER glucosidase II to allow entry of glycoproteins into the calnexin/calreticulin cycle. Mol Cell 2005, 19:183-195.
24. Nilsson I., von Heijne G. Determination of the distance between the oligosaccharyltransferase active site and the endoplasmic reticulum membrane. J Biol Chem 1993, 268:5798-5801.
25. Lizak C., Gerber S., Numao S., Aebi M., Locher K.P. X-ray structure of a bacterial oligosaccharyltransferase. Nature 2011, 474:350-355.
26. Pfeffer S., Burbaum L., Unverdorben P., Pech M., Chen Y., Zimmermann R., Beckmann R., Forster F. Structure of the native Sec61 protein-conducting channel. Nat Commun 2015, 6:8403.
27. Pfeffer S., Dudek J., Gogala M., Schorr S., Linxweiler J., Lang S., Becker T., Beckmann R., Zimmermann R., Forster F. Structure of the mammalian oligosaccharyl-transferase complex in the native ER protein translocon. Nat Commun 2014, 5:3072.
28. Ruiz-Canada C., Kelleher D.J., Gilmore R. Cotranslational and posttranslational N-glycosylation of polypeptides by distinct mammalian OST isoforms. Cell 2009, 136:272-283.
29. Conti B.J., Devaraneni P.K., Yang Z., David L.L., Skach W.R. Cotranslational stabilization of Sec62/63 within the ER Sec61 translocon is controlled by distinct substrate-driven translocation events. Mol Cell 2015, 58:269-283.
30. Nilsson I., Kelleher D.J., Miao Y., Shao Y., Kreibich G., Gilmore R., Von Heijne G., Johnson A.E. Photocross-linking of nascent chains to the STT3 subunit of the oligosaccharyltransferase complex. J Cell Biol 2003, 161:715-725.
31. Shrimal S., Gilmore R. Glycosylation of closely spaced acceptor sites in human glycoproteins. J Cell Sci 2013, 126:5513-5523.
32. Cherepanova N.A., Gilmore R. Mammalian cells lacking either the cotranslational or posttranslocational oligosaccharyltransferase complex display substrate-dependent defects in asparagine linked glycosylation. Sci Rep 2016, 6:20946.
33. Shrimal S., Ng B.G., Losfeld M.E., Gilmore R., Freeze H.H. Mutations in STT3A and STT3B cause two congenital disorders of glycosylation. Hum Mol Genet 2013, 22:4638-4645.
34. Bas T., Gao G.Y., Lvov A., Chandrasekhar K.D., Gilmore R., Kobertz W.R. Post-translational N-glycosylation of type I transmembrane KCNE1 peptides: implications for membrane protein biogenesis and disease. J Biol Chem 2011, 286:28150-28159.
35. Malaby H.L., Kobertz W.R. Molecular determinants of co- and post-translational N-glycosylation of type I transmembrane peptides. Biochem J 2013, 453:427-434.
36. Malaby H.L., Kobertz W.R. The middle x residue influences cotranslational N-glycosylation consensus site skipping. Biochemistry 2014, 53:4884-4893.
37. Mohorko E., Owen R.L., Malojcic G., Brozzo M.S., Aebi M., Glockshuber R. Structural basis of substrate specificity of human oligosaccharyl transferase subunit N33/Tusc3 and its role in regulating protein N-glycosylation. Structure 2014, 22:590-601.
38. Schulz B.L., Stirnimann C.U., Grimshaw J.P., Brozzo M.S., Fritsch F., Mohorko E., Capitani G., Glockshuber R., Grutter M.G., Aebi M. Oxidoreductase activity of oligosaccharyltransferase subunits Ost3p and Ost6p defines site-specific glycosylation efficiency. Proc Natl Acad Sci USA 2009, 106:11061-11066.
39. Schulz B.L., Aebi M. Analysis of glycosylation site occupancy reveals a role for Ost3p and Ost6p in site-specific N-glycosylation efficiency. Mol Cell Proteomics 2009, 8:357-364.
40. 2+ transporter with channel-like properties. BMC Genomics 2005, 6:48.
41. Zhou H., Clapham D.E. Mammalian MagT1 and TUSC3 are required for cellular magnesium uptake and vertebrate embryonic development. Proc Natl Acad Sci USA 2009, 106:15750-15755.
42. 2+ revealed by human T-cell immunodeficiency. Nature 2011, 475:471-476.
43. Zheng J., Mao X., Ling J., Chen C., Zhang W. Role of magnesium transporter subtype 1 (MagT1) in the osteogenic differentiation of rat bone marrow stem cells. Biol Trace Elem Res 2015.
44. Schweigel M., Kolisek M., Nikolic Z., Kuzinski J. Expression and functional activity of the Na/Mg exchanger, TRPM7 and MagT1 are changed to regulate Mg homeostasis and transport in rumen epithelial cells. Magnes Res 2008, 21:118-123.
45. Wolf F.I., Trapani V., Simonacci M., Mastrototaro L., Cittadini A., Schweigel M. Modulation of TRPM6 and Na(+)/Mg(2+) exchange in mammary epithelial cells in response to variations of magnesium availability. J Cell Physiol 2010, 222:374-381.
46. MacGrogan D., Levy A., Bova G.S., Isaacs W.B., Bookstein R. Structure and methylation-associated silencing of a gene within a homozygously deleted region of human chromosome band 8p22. Genomics 1996, 35:55-65.
47. Horak P., Tomasich E., Vanhara P., Kratochvilova K., Anees M., Marhold M., Lemberger C.E., Gerschpacher M., Horvat R., Sibilia M., et al. TUSC3 loss alters the ER stress response and accelerates prostate cancer growth in vivo. Sci Rep 2014, 4:3739.
48. Sato T., Sako Y., Sho M., Momohara M., Suico M.A., Shuto T., Nishitoh H., Okiyoneda T., Kokame K., Kaneko M., et al. STT3B-dependent posttranslational N-glycosylation as a surveillance system for secretory protein. Mol Cell 2012, 47:99-110.
49. Dersh D., Jones S.M., Eletto D., Christianson J.C., Argon Y. OS-9 facilitates turnover of nonnative GRP94 marked by hyperglycosylation. Mol Biol Cell 2014, 25:2220-2234.
50. Moriconi C., Ordonez A., Lupo G., Gooptu B., Irving J.A., Noto R., Martorana V., Manno M., Timpano V., Guadagno N.A., et al. Interactions between N-linked glycosylation and polymerisation of neuroserpin within the endoplasmic reticulum. FEBS J 2015, 282:4565-4579.
51. Hennet T., Cabalzar J. Congenital disorders of glycosylation: a concise chart of glycocalyx dysfunction. Trends Biochem Sci 2015, 40:377-384.
52. Freeze H.H. Understanding human glycosylation disorders: biochemistry leads the charge. J Biol Chem 2013, 288:6936-6945.
53. Haeuptle M.A., Hennet T. Congenital disorders of glycosylation: an update on defects affecting the biosynthesis of dolichol-linked oligosaccharides. Hum Mutat 2009, 30:1628-1641.
54. Jones M.A., Ng B.G., Bhide S., Chin E., Rhodenizer D., He P., Losfeld M.E., He M., Raymond K., Berry G., et al. DDOST mutations identified by whole-exome sequencing are implicated in congenital disorders of glycosylation. Am J Hum Genet 2012, 90:363-368.
55. Losfeld M.E., Ng B.G., Kircher M., Buckingham K.J., Turner E.H., Eroshkin A., Smith J.D., Shendure J., Nickerson D.A., Bamshad M.J., et al. A new congenital disorder of glycosylation caused by a mutation in SSR4, the signal sequence receptor 4 protein of the TRAP complex. Hum Mol Genet 2014, 23:1602-1605.
56. Ng B.G., Raymond K., Kircher M., Buckingham K.J., Wood T., Shendure J., Nickerson D.A., Bamshad M.J., University of Washington Center for Mendelian G, Wong J.T., et al. Expanding the molecular and clinical phenotype of SSR4-CDG. Hum Mutat 2015, 36:1048-1051.
57. Molinari F., Foulquier F., Tarpey P.S., Morelle W., Boissel S., Teague J., Edkins S., Futreal P.A., Stratton M.R., Turner G., et al. Oligosaccharyltransferase-subunit mutations in nonsyndromic mental retardation. Am J Hum Genet 2008, 82:1150-1157.
58. Garshasbi M., Kahrizi K., Hosseini M., Nouri Vahid L., Falah M., Hemmati S., Hu H., Tzschach A., Ropers H.H., Najmabadi H., et al. A novel nonsense mutation in TUSC3 is responsible for non-syndromic autosomal recessive mental retardation in a consanguineous Iranian family. Am J Med Genet A 2011, 155A:1976-1980.
59. El Chehadeh S., Bonnet C., Callier P., Beri M., Dupre T., Payet M., Ragon C., Mosca-Boidron A.L., Marle N., Mugneret F., et al. Homozygous truncating intragenic duplication in TUSC3 responsible for rare autosomal recessive nonsyndromic intellectual disability with no clinical or biochemical metabolic markers. JIMD Rep 2015, 20:45-55.
60. Zhang M.J., Xing L.X., Cui M., Yang X., Shi J.G., Li J., Zhang K.J., Zheng Z.J., Zhang F.C., Li J.L., et al. Association of TUSC3 gene polymorphisms with non-syndromic mental retardation based on nuclear families in the Qinba mountain area of China. Genet Mol Res 2015, 14:5022-5030.
61. Ravell J., Chaigne-Delalande B., Lenardo M. X-linked immunodeficiency with magnesium defect, Epstein-Barr virus infection, and neoplasia disease: a combined immune deficiency with magnesium defect. Curr Opin Pediatr 2014, 26:713-719.
62. Dhalla F., Murray S., Sadler R., Chaigne-Delalande B., Sadaoka T., Soilleux E., Uzel G., Miller J., Collins G.P., Hatton C.S., et al. Identification of a novel mutation in MAGT1 and progressive multifocal leucoencephalopathy in a 58-year-old man with XMEN disease. J Clin Immunol 2015, 35:112-118.
63. 2+ regulates cytotoxic functions of NK and CD8 T cells in chronic EBV infection through NKG2D. Science 2013, 341:186-191.
64. Patiroglu T., Haluk Akar H., Gilmour K., Unal E., Akif Ozdemir M., Bibi S., Burns S., Chiang S.C., Schlums H., Bryceson Y.T., et al. A case of XMEN syndrome presented with severe auto-immune disorders mimicking autoimmune lymphoproliferative disease. Clin Immunol 2015, 159:58-62.
65. Piton A., Redin C., Mandel J.L. XLID-causing mutations and associated genes challenged in light of data from large-scale human exome sequencing. Am J Hum Genet 2013, 93:368-383.
66. Shrimal S., Gilmore R. Reduced expression of the oligosaccharyltransferase exacerbates protein hypoglycosylation in cells lacking the fully assembled oligosaccharide donor. Glycobiology 2015, 25:774-783.